Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TheraBiologics Inc.
DescriptionNSC line modified to express the enzyme carboxylesterase (CE)
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today